Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Feb 22, 2019, 21:04 ET Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today that it has increased the maximum...


Feb 22, 2019, 14:35 ET Health Canada Approves Otsuka and Lundbeck's REXULTI® (brexpiprazole) as Adjunctive Treatment of Major Depressive Disorder

MONTREAL, Feb. 22, 2019 /CNW Telbec/ - Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Canada Inc. (Lundbeck) announce that Health Canada...


Feb 22, 2019, 07:43 ET Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes

Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has launched an offering of $500,000,000...


Feb 22, 2019, 07:30 ET Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada

Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of...


Feb 21, 2019, 08:30 ET MYM Proceeds With the Development of 400 Hectares of Outdoor Medical Cannabis Cultivation in Australia

MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) ("MYM" or "The Company") is pleased to announce it has established MYM Australia Pty Ltd. in the...


Feb 21, 2019, 08:21 ET Kneat and HCL Technologies Partner to Deliver Digital Validation Solutions to Life Sciences

HALIFAX, Feb. 21, 2019 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat") is pleased to announce that it has signed a partnership agreement with HCL...


Feb 21, 2019, 08:00 ET Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

NASDAQ: CORV TSX: CORV VANCOUVER, Feb. 21, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused...


Feb 21, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

MISSISSAUGA, ON, Feb. 21, 2019 /CNW/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical...


Feb 20, 2019, 16:15 ET Competition Bureau completes investigation into alleged abuse of dominance by Janssen Inc.

OTTAWA, Feb. 20, 2019 /CNW/ - The Competition Bureau announced today that it is closing an investigation into allegations of abuse of dominance by...


Feb 20, 2019, 09:00 ET Kneat Announces Closing of $6,339,375 Public Equity Financing and Concurrent $2,178,159 Non-Brokered Private Placement Equity Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ HALIFAX, Feb. 20, 2019 /CNW/ - kneat.com, inc....


Feb 20, 2019, 08:00 ET AbbVie's HUMIRA® (Adalimumab) Approved by Health Canada to Treat Pediatric Patients with Chronic Non-infectious Anterior Uveitis

The approval marks HUMIRA as the only approved biologic treatment option in Canada for pediatric patients from two years of age with chronic...


Feb 20, 2019, 08:00 ET Valeo Pharma Announces Listing of its Shares on the Canadian Securities Exchange Under the Symbol VPH

MONTREAL, Feb. 20, 2019 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) ("Valeo Pharma") a Canadian specialty pharmaceutical company, is pleased to...


Feb 20, 2019, 07:15 ET CannTrust to Start Trading on NYSE February 25

VAUGHAN, ON, Feb. 20, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST) is pleased to announce that it has satisfied all...


Feb 20, 2019, 07:00 ET Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance

Fourth-Quarter 2018 Financial Results Revenues of $2.121 Billion GAAP Net Loss of $344 Million Adjusted EBITDA (non-GAAP)1 of $858 Million Full-Year...


Feb 20, 2019, 07:00 ET Aurora Cannabis Announces Key Changes to its Board of Directors

TSX | NYSE: ACB EDMONTON, Feb. 20, 2019 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) ...


Feb 20, 2019, 03:05 ET Weekend Unlimited Completes Acquisition Of Jamaican Assets

Weekend Unlimited Inc. ("Weekend" or the "Company") (CSE: POT) – (FSE: 0OS1) – (OTCMKTS: WKULF) having announced the signing of a definitive...


Feb 19, 2019, 17:13 ET Valeo Pharma Completes Private Placement

MONTREAL, Feb. 19, 2019 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) ("Valeo Pharma" or the "Corporation") a Canadian specialty pharmaceutical...


Feb 19, 2019, 14:30 ET New Drug Landscape Dominated by High-cost Medicines

OTTAWA, Feb. 19, 2019 /CNW/ - The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information...


Feb 19, 2019, 14:17 ET Senzer's ISO Certification: A First for the Pharmaceutical Cannabinoid Sector

In what is believed to be the first-ever ISO certification for the Design and Development of a medical device to deliver pharmaceutical-grade...


Feb 19, 2019, 09:00 ET Continued Market Expansion is Driving Cannabis Companies to New Regions

The expansion of the cannabis industry has led companies involved in the marketplace to expand internationally as larger players are extending their...


Feb 19, 2019, 08:30 ET Chemistree Granted Conditional Use Permit for Desert Hot Springs Land

VANCOUVER, Feb. 19, 2019 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is...


Feb 19, 2019, 08:10 ET Liht Cannabis Corp. Awarded Second Certification For Its Cultivation Facilities in Las Vegas, Nevada

KELOWNA, BC, Feb. 19, 2019 /CNW/ - Liht Cannabis Corp. ((CSE: LIHT) (OTCQX: LIHTF) or the "Company") is very proud to announce that it has received...


Feb 19, 2019, 08:05 ET Nobel Prize Winner Professor Aaron Ciechanover appointed senior member on the advisory committee of Panaxia Pharmaceutical

The pharma company, Panaxia Pharmaceutical Industries LTD, an Israeli pharmaceutical cannabis company, announced today that Nobel Prize winner in...


Feb 19, 2019, 07:00 ET Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

Bausch Health Companies Inc. (NYSE/TSX: BHC) and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton...


Feb 19, 2019, 06:30 ET HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

TORONTO, Feb. 19, 2019 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a specialty pharmaceutical company focused on central...